Masana, L, Correig, E, Rodriguez-Borjabad, C, Anoro, E, Arroyo, JA, Jerico, C, Pedragosa, A, la Miret, M, Naf, S, Pardo, A, Perea, V, Perez-Bernalte, R, Plana, N, Ramirez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2)DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7.100(Q1/1D).

Tornero-Molina, J, Alperi-Lopez, M, Castellvi, I, de Agustin-de Oro, JJ, Escudero, A, Garcia-Vicuna, R, Gonzalez-Gay, MA, Hidalgo, C, Rubio, E, Sanmarti, R, Casamira, N, Calvo-Alen, J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1)DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. IF:(Q/D).

Ortiz, MA, Diaz-Torne, C, De Agustin, JJ, Estrada, P, Reina, D, Hernandez, MV, Sang, HY, Zamora, C, Canto, E, Corominas, H, Vidal, S. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules. 2024; 14(1)DOI:10.3390/biom14010001. PMID:38275742. IF:4.800(Q1/3D).

Molina, JT, Hernández-Cruz, B, Corominas, H. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(1)DOI:10.3390/jcm13010048. PMID:38202055. IF:2.900(Q1/2D).

Balsa A., Díaz del Campo Fontecha P., Silva Fernández L., Valencia Martín J., Nistal Martínez V., León Vázquez F., Hernández Hernández M.V., Corominas H., Cáliz Cáliz R., Aguado García J.M., Candelas Rodríguez G., Ibargoyen Roteta N., Martí Carbajal A., Plana Farras M.N., Puñal Riobóo J., Park H.S., Triñanes Pego Y., Villaverde García V.. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reuma.2023.07.001. PMID:. IF:(Q/D).

Sainz, L, Riera, P, Moya, P, Bernal, S, Casademont, J, Diaz-Torne, C, Millan, AM, Park, HS, Lasa, A, Corominas, H. Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2023; 25(1)DOI:10.1186/s13075-023-03209-1. PMID:38001504. IF:4.400(Q1/3D).

Valero-Martínez, C, Urgelles, JF, Sallés, M, Joven-Ibáñez, BE, de Juanes, A, Ramírez, J, Juanola, X, Almodóvar, R, Laiz, A, Moreno, M, Pujol, M, Beltrán, E, Pinto-Tasende, JA, Crespí, L, Sala-Icardo, L, Castañeda, S, García-Vicuña, R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5.700(Q1/3D).

Osuna-Gomez, R, Castellvi, I, Mulet, M, Ortiz, MA, Brough, DE, Sabzevari, H, Semnani, RT, Vidal, S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310567. PMID:37445745. IF:4.900(Q1/3D).

De Miguel, E, Sanchez-Costa, JT, Estrada, P, Munoz, A, Martinez, CV, Alvarado, PM, Garcia-Villanueva, MJ, Angeles, VAN, Da Veiga, CGL, Frutos, AR, Ivorra, JAR, Arrabal, SL, Rocha, MV, Iniguez, CL, Garcia-Gonzalez, M, Molina-Almela, C, Villar, MA, Mas, AJ, Gonzalez-Gay, MA, Blanco, R. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022). RMD Open. 2023; 9(2)DOI:10.1136/rmdopen-2022-002507corr1. PMID:. IF:5.100(Q1/2D).

Morillon, MB, Norup, A, Singh, JA, Dalbeth, N, Taylor, WJ, Kennedy, MA, Pedersen, BM, Grainger, R, Tugwell, P, Perez-Ruiz, F, Diaz-Torne, C, Edwards, NL, Shea, B, Ellingsen, TJ, Christensen, R, Stamp, LK. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 60DOI:10.1016/j.semarthrit.2023.152191. PMID:36963128. IF:4.600(Q1/2D).

Díaz-Torné C., Pou M.A., Rodríguez-Díez B., Pujol-Ribera E.. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatologia Clinica. 2023; 19(3)DOI:10.1016/j.reuma.2022.03.009. PMID:36058814. IF:(Q/D).

Sanmarti, R, Corominas, H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5)DOI:10.3390/jcm12051734. PMID:36902522. IF:3.000(Q1/2D).

Hernández-de Sosa N., Cardona Corrales R., Casademont J.. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24DOI:10.12659/AJCR.938548. PMID:36841939. IF:(Q/D).

Sainz L., Riera P., Moya P., Bernal S., Casademont J., Díaz-Torné C., Millán A.M., Park H.S., Lasa A., Corominas H.. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1)DOI:10.3390/jpm13010061. PMID:36675722. IF:3.000(Q1/2D).

Colalillo A., Hoffmann-Vold A.-M., Pellicano C., Romaniello A., Gabrielli A., Hachulla E., Smith V., Simeón-Aznar C.-P., Castellví I., Airò P., Truchetet M.-E., Siegert E., Distler O., Rosato E.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4)DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9.200(Q1/1D).

Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Tasende J.A.P., Baute J.J.B., Joven Ibáñez B., Toniolo E., Ramírez J., Montero N., Pruenza García-Hinojosa C., Serrano García A.. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12030931. PMID:36769579. IF:3.000(Q1/2D).

Jeria-Navarro S., Gomez-Gomez A., Park H.S., Calvo-Aranda E., Corominas H., Pou M.A., Diaz-Torne C.. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3.100(Q1/2D).

Narváez J., Aburto M., Seoane-Mato D., Bonilla G., Acosta O., Candelas G., Cano-Jiménez E., Castellví I., González-Ruiz J.M., Corominas H., López-Muñiz B., Martín-López M., Robles-Pérez A., Mena-Vázquez N., Rodríguez-Portal J.A., Ortiz A.M., Sabater-Abad C., Castrejón I., dos Santos R., Garrote-Corral S., Maese J., Silva-Fernández L., Castañeda S., Valenzuela C.. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2)DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:(Q/D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., Marcos A.G.. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1)DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3.400(Q2/3D).

Oteo J.A., Corominas H., Escudero R., Fariñas-Guerrero F., García-Moncó J.C., Goenaga M.A., Guillén S., Mascaró J.M., Portillo A.. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1)DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2.600(Q3/6D).